PT Medikaloka Hermina Tbk (IDX:HEAL)
1,145.00
-25.00 (-2.14%)
Apr 29, 2026, 11:58 AM WIB
PT Medikaloka Hermina Tbk Ratios and Metrics
Market cap in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 17,978,162 | 21,128,181 | 24,270,749 | 21,692,778 | 22,417,924 | 15,701,180 | Upgrade
|
| Market Cap Growth | -6.04% | -12.95% | 11.88% | -3.23% | 42.78% | 50.12% | Upgrade
|
| Enterprise Value | 22,008,977 | 25,017,928 | 28,021,821 | 24,317,744 | 24,642,985 | 18,018,084 | Upgrade
|
| Last Close Price | 1170.00 | 1375.00 | 1616.68 | 1468.34 | 1519.49 | 1044.36 | Upgrade
|
| PE Ratio | 41.20 | 49.19 | 45.29 | 49.60 | 75.08 | 15.77 | Upgrade
|
| Forward PE | 32.14 | 34.23 | 34.94 | 36.69 | 42.12 | 21.13 | Upgrade
|
| PS Ratio | 2.52 | 2.96 | 3.61 | 3.75 | 4.57 | 2.68 | Upgrade
|
| PB Ratio | 2.49 | 2.93 | 4.14 | 4.17 | 4.79 | 3.54 | Upgrade
|
| P/TBV Ratio | 3.17 | 3.73 | 5.46 | 5.61 | 6.52 | 4.75 | Upgrade
|
| P/FCF Ratio | - | - | - | - | - | 24.43 | Upgrade
|
| P/OCF Ratio | 15.80 | 18.57 | 21.34 | 16.44 | 25.84 | 8.46 | Upgrade
|
| PEG Ratio | 2.03 | 11.80 | 11.80 | 11.80 | 11.80 | 0.73 | Upgrade
|
| EV/Sales Ratio | 3.09 | 3.51 | 4.17 | 4.20 | 5.03 | 3.07 | Upgrade
|
| EV/EBITDA Ratio | 12.43 | 14.16 | 16.08 | 16.68 | 21.66 | 8.21 | Upgrade
|
| EV/EBIT Ratio | 22.72 | 25.83 | 26.45 | 29.75 | 41.91 | 10.21 | Upgrade
|
| EV/FCF Ratio | -35.95 | - | - | - | - | 28.03 | Upgrade
|
| Debt / Equity Ratio | 0.45 | 0.45 | 0.55 | 0.44 | 0.37 | 0.38 | Upgrade
|
| Debt / EBITDA Ratio | 1.82 | 1.82 | 1.85 | 1.54 | 1.52 | 0.76 | Upgrade
|
| Debt / FCF Ratio | - | - | - | - | - | 2.59 | Upgrade
|
| Net Debt / Equity Ratio | 0.35 | 0.35 | 0.44 | 0.27 | 0.21 | 0.09 | Upgrade
|
| Net Debt / EBITDA Ratio | 1.41 | 1.41 | 1.49 | 0.96 | 0.85 | 0.17 | Upgrade
|
| Net Debt / FCF Ratio | -4.08 | -4.08 | -2.27 | -5.17 | -3.68 | 0.59 | Upgrade
|
| Asset Turnover | 0.64 | 0.64 | 0.69 | 0.71 | 0.65 | 0.84 | Upgrade
|
| Inventory Turnover | 31.62 | 31.62 | 34.41 | 35.54 | 34.24 | 34.97 | Upgrade
|
| Quick Ratio | 1.11 | 1.11 | 1.04 | 1.17 | 0.98 | 1.46 | Upgrade
|
| Current Ratio | 1.22 | 1.22 | 1.13 | 1.26 | 1.05 | 1.53 | Upgrade
|
| Return on Equity (ROE) | 8.40% | 8.40% | 12.46% | 11.32% | 8.31% | 33.03% | Upgrade
|
| Return on Assets (ROA) | 5.39% | 5.39% | 6.83% | 6.23% | 4.85% | 15.84% | Upgrade
|
| Return on Invested Capital (ROIC) | 7.34% | 7.75% | 10.69% | 10.51% | 8.87% | 31.54% | Upgrade
|
| Return on Capital Employed (ROCE) | 9.70% | 9.70% | 12.10% | 11.30% | 10.00% | 29.60% | Upgrade
|
| Earnings Yield | 2.39% | 2.03% | 2.21% | 2.02% | 1.33% | 6.34% | Upgrade
|
| FCF Yield | -3.40% | -2.90% | -4.71% | -1.25% | -1.17% | 4.09% | Upgrade
|
| Dividend Yield | 0.88% | - | 0.65% | 0.58% | 0.46% | 0.57% | Upgrade
|
| Payout Ratio | 36.19% | 36.19% | 23.61% | 23.20% | 29.02% | 7.38% | Upgrade
|
| Buyback Yield / Dilution | -1.90% | -1.90% | -0.88% | 0.01% | 1.31% | -0.16% | Upgrade
|
| Total Shareholder Return | -1.03% | -1.90% | -0.23% | 0.59% | 1.77% | 0.42% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.